Trial intelligence / Profile preview

Effect of montelukast in asthma exacerbation

IRCT20171227038108N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of montelukast in asthma, sponsored by Mazandaran University of Medical Sciences. Started Jan 2018; status: completed.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT20171227038108N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171227038108N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call